Ekotizim

Mahsulotlar

AkademIndexIlmiy qidiruv va kashfiyot
AkademScholarMetrikalar va ilmiy tahlil
AkademIDtez oradaMuallif identifikatori va profillar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API

Loyiha haqida Qamrov Yordam

← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

210 ta ish

Ish: The Radiosensitizing Potentials of Silymarin/Silibinin in Cancer: A Systematic Review

Improved dissolution and bioavailability of silymarin delivered by a solid dispersion prepared using supercritical fluids
Gang Yang, Yaping Zhao, Nianping Feng +3
Maqola20144 iqtibos
ABI
Chemoenzymatic Preparation of Oligoglycosides of Silybin, the Flavonolignan from Silybum marianum
Vilı́m Šimánek, Jiří Kubisch, Petr Sedmera +4
Maqola20014 iqtibos
ABI
Antioxidant properties of silybin glycosides
Pavel Kosina, Vladim�r K en, Rolf Gebhardt +3
Maqola20024 iqtibos
ABI
Toward the Definition of the Mechanism of Action of Silymarin: Activities Related to Cellular Protection From Toxic Damage Induced by Chemotherapy
Maria Cristina Comelli, U. Mengs, Carl Christoph Schneider +1
Sharh maqola20074 iqtibos
ABI
Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives
Peter Surai
Sharh maqola20154 iqtibos
ABI
Silymarin inhibits function of the androgen receptor by reducing nuclear localization of the receptor in the human prostate cancer cell line LNCaP
W. Zhu
Maqola20014 iqtibos
ABI
Silybin and Silymarin - New and Emerging Applications in Medicine
Radek Gažák, Daniela Walterová, Vladimı́r Křen
Sharh maqola20074 iqtibos
ABI
Flavonolignan 2,3-dehydroderivatives: Preparation, antiradical and cytoprotective activity
Michaela Pyszková, Michal Biler, David Biedermann +11
Maqola20154 iqtibos
ABI
Preparation, Pharmacokinetics and Body Distribution of Silymarin-Loaded Solid Lipid Nanoparticles After Oral Administration
Jun He, Shi-xiang Hou, Weigen Lu +2
Maqola20074 iqtibos
ABI
Silymarin suppressed lung cancer growth in mice via inhibiting myeloid-derived suppressor cells
Tiancong Wu, Wen Liu, Wenjie Guo +1
Maqola20164 iqtibos
ABI
Silymarin for Liver Disease
Ludovico Abenavoli, Nataša Milić
Bob20174 iqtibos
ABI
Flavonolignan 2,3-dehydrosilydianin activates Nrf2 and upregulates NAD(P)H:quinone oxidoreductase 1 in Hepa1c1c7 cells
Lenka Roubalová, Albena T. Dinkova‐Kostova, David Biedermann +3
Maqola20174 iqtibos
ABI
Quality by design based silymarin nanoemulsion for enhancement of oral bioavailability
Amrita Nagi, Babar Iqbal, Shobhit Kumar +3
Maqola20174 iqtibos
ABI
HM015k, a Novel Silybin Derivative, Multi-Targets Metastatic Ovarian Cancer Cells and Is Safe in Zebrafish Toxicity Studies
Haneen Amawi, Noor Hussein, Chandrabose Karthikeyan +7
Maqola20174 iqtibos
ABI
Effects of Silymarin-Loaded Nanoparticles on HT-29 Human Colon Cancer Cells
Maryam Mombeini, Ghasem Saki, Layasadat Khorsandi +1
Maqola20184 iqtibos
ABI
Antioxidant effects and mechanism of silymarin in oxidative stress induced cardiovascular diseases
Abdoh Taleb, Khalil Ali Ahmad, Awais Ullah Ihsan +6
Sharh maqola20184 iqtibos
ABI
Silymarin Nanoformulation as Potential Anticancer Agent in Experimental Ehrlich Ascites Carcinoma-Bearing Animals
Mohamed El‐Far, Neven Salah, Alaa Essam +2
Maqola20184 iqtibos
ABI
Silymarin-laden PVP-PEG polymeric composite for enhanced aqueous solubility and dissolution rate: Preparation and in vitro characterization
Abid Mehmood Yousaf, Usman Rashid Malik, Yasser Shahzad +2
Maqola20184 iqtibos
ABI
Selective Synthesis of 3-O-Palmitoyl-Silybin, a New-to-Nature Flavonolignan with Increased Protective Action against Oxidative Damages in Lipophilic Media
Samantha Drouet, Joël Doussot, Laurine Garros +6
Maqola20184 iqtibos
ABI
Formulation and optimization of lyophilized nanosuspension tablets to improve the physicochemical properties and provide immediate release of silymarin
Ahmed H. Ibrahim, Emil Rosqvist, Jan‐Henrik Smått +5
Maqola20194 iqtibos
ABI
Mesoporous silica nanoparticles, a safe option for silymarin delivery: preparation, characterization, and in vivo evaluation
Sarah Nasr, Maha M. A. Nasra, Heba A. Hazzah +1
Maqola20194 iqtibos
ABI
Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review
Vahid Soleimani, Parisa Sadat Delghandi, Seyed Adel Moallem +1
Sharh maqola20194 iqtibos
ABI
A pilot study of the UVA-photoprotective potential of dehydrosilybin, isosilybin, silychristin, and silydianin on human dermal fibroblasts
Alena Rajnochová Svobodová, Eva Gabrielová, Jitka Ulrichová +3
Maqola20194 iqtibos
ABI
Formulation Strategies for Enhancing the Bioavailability of Silymarin: The State of the Art
Alfonso Di Costanzo, Ruggero Angelico
Sharh maqola20194 iqtibos
ABI
Silymarin antiproliferative and apoptotic effects: Insights into its clinical impact in various types of cancer
Tahereh Hosseinabadi, Zahra Lorigooini, Maryam Tabarzad +4
Sharh maqola20194 iqtibos
ABI